Douglas Ward

Statistics

Publications

Citations

3.9K

H-Index

Active since

1990

Affiliations

Centers for Disease Control and Prevention(Current)

Cerner (United States)

Northwestern University

University of Illinois Chicago

Gilead Sciences (United States)

Douglas Ward is an author at Centers for Disease Control and Prevention specializing in antiretroviral therapy, pharmacotherapy, and antiviral therapy.

Publications per year

1990–2022

Publications

Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral Therapy

Tae‐Wook Chun, David C. Nickle, J. Shawn Justement et al. · The Journal of Infectious Diseases · 2008 · 564 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

Scott D. Holmberg, Anne C. Moorman, John Williamson et al. · The Lancet · 2002 · 489 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Clinical assessment of HIV-associated lipodystrophy in an ambulatory population

Kenneth A. Lichtenstein, Douglas Ward, Anne C. Moorman et al. · AIDS · 2001 · 426 citations

Pharmacy, Pharmacotherapy, Hiv Prevention +16

Incidence of and Risk Factors for Lipoatrophy (Abnormal Fat Loss) in Ambulatory HIV-1-Infected Patients

Kenneth Lichtenstein, Kathleen M. Delaney, Carl Armon et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2003 · 203 citations

Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +15

Switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from dolutegravir plus abacavir and lamivudine in virologically suppressed adults with HIV-1: 48 week results of a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Jean‐Michel Molina, Douglas Ward, Indira Brar et al. · The Lancet HIV · 2018 · 203 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

1–5 of 36